Prev Close | 0.56 |
Open | 0.59 |
Day Low/High | 0.54 / 0.59 |
52 Wk Low/High | 0.23 / 1.07 |
Volume | 1.64M |
Avg Volume | 1.37M |
Prev Close | 0.56 |
Open | 0.59 |
Day Low/High | 0.54 / 0.59 |
52 Wk Low/High | 0.23 / 1.07 |
Volume | 1.64M |
Avg Volume | 1.37M |
Exchange | NASDAQ |
Shares Outstanding | 33.17M |
Market Cap | 18.44M |
EPS | -0.30 |
P/E Ratio | N/A |
Div & Yield | N.A. (N.A) |
Biotech investors should keep a close eye on the progress in this huge potential market.
If you can't beat them, then join them.
I've got my eye on steel and biotechnology names to put cash to work.
Thin trading is impeding momentum, but here are 4 stocks on my radar.
Will pension funds sell stocks after their run higher in order to maintain the same allocation levels to bonds and equities?
Today's action is a classic example.
But I'm expecting that things will slow into the Fed news.
They offer a nice shelter for the headwinds now hitting equities.
The market seems to be severely discounting DynaVax's chances of approval for its hep-B treatment.
Drugs for liver diseases are good opportunities.
The danger is that market players start selling out of boredom.
Here we go. By Bret Jensen The market is slightly up across the board in the first 30 minutes of trading, and the 10-year Treasury yield is approaching 2.65%. Deckers Outdoor (DECK) is nicely up due to an upgrade at Wells Fargo, which now has price ...